Cardiotoxicity is a leading cause for drug attrition during pharmaceutical development and has resulted in numerous preventable patient deaths.
http://circ.ahajournals.org/content/early/2013/03/20/CIRCULATIONAHA.113.001883.short?rss=1
http://circ.ahajournals.org/content/early/2013/03/20/CIRCULATIONAHA.113.001883.short?rss=1
No comments:
Post a Comment